Dupilumab trial ‘confirms safety profile’ over three years
In addition, patient lung function improved and exacerbation rates were low, researchers say.
Tag: ERS Congress 2020 – European Respiratory Society
First-in-class drug for chronic cough shows efficacy
Only the higher dose gave better results than placebo in two parallel phase three trials, investigators report.
Bronchoscopies ‘add diagnostic certainty in COVID-19’
Specimens taken by bronchoalveolar lavage show the highest rates of positivity for SARS-CoV-2, researchers say.
Poor lung function linked with cognitive decline, study shows
Women appear to be more at risk, the authors say.
App predicts worsening asthma from night-time coughs
The data might facilitate early medication titration to prevent exacerbations, researchers say.
What happens to lung function after COVID-19?
The first European patient follow-up results are coming in.
Surgery could benefit patients with apnoea who reject CPAP
Australian surgeons have developed a novel procedure to decrease throat obstruction.
Lung damage after COVID-19 does improve in time
Impairment lingers but lungs appear to 'have a repair mechanism', first study shows.
